Yahoo
    NasdaqCM - Delayed Quote USD

    bioAffinity Technologies, Inc. (BIAFW)

    0.2180 0.0000 (0.00%)
    At close: October 29 at 10:26:55 AM EDT
    Loading Chart for BIAFW
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

    bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
    Business Wire 4mo ago
    bioAffinity Technologies Announces Closing of $3.2 Million Offering

    bioAffinity Technologies Announces Closing of $3.2 Million Offering
    Business Wire 4mo ago
    WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering

    WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering
    PR Newswire 4mo ago
    bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

    bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?
    Zacks 6mo ago
    bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month

    bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month
    Business Wire 3d ago
    bioAffinity Technologies expands Lung diagnostics pipeline into COPD and Asthma

    bioAffinity Technologies expands Lung diagnostics pipeline into COPD and Asthma
    Proactive 5d ago
    bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026

    bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
    Business Wire 17d ago
    bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026

    bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026
    Business Wire 19d ago
    WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

    WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
    PR Newswire 23d ago
    bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

    bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
    Business Wire 23d ago
    WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

    WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
    PR Newswire 23d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: